Revolutionizing Kidney Care: The Mitochondria Connection

In this episode we explore how mitochondrial dysfunction drives kidney disease, the expanding role of SGLT2 inhibitors, and the systemic nature of CKD-related risks. We highlight breakthroughs in biomarkers, nanotechnology-based therapies, and new pediatric guidelines—revealing a shift toward precision and preventive nephrology.